IL10 and inflammatory bowel disease: The potent suppressive function of IL-10 is illustrated by the development of very early onset inflammatory bowel disease (VEO-IBD), defined as presentation of IBD in children <6 y of age (4), among patients with monogenic variants in IL-10 or its receptors (5, 6).